Antihyperlipidemic effect of Peucedanum Pastinacifolium extract in streptozotocin-induced diabetic rats

Clinics

Volumn 65, Issue 6, 2010, Pages 629-633

  Movahedian, Ahmad ^a   Zolfaghari, Behzad ^a   Sajjadi, S Ebrahim ^a   Moknatjou, Reza ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholesterol; Hypercholesterolemia; Lipoproteins; P. pastinacifolium

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; PLANT EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BLOOD; DRUG SCREENING; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; PHYTOTHERAPY; RANDOMIZATION; RAT; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; HYPOLIPIDEMIC AGENTS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; STREPTOZOCIN; TRIGLYCERIDES;

EID: 77954944216     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000600011     Document Type: Article

References (32)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
2. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008;31:96-98.
3. Tang WH, Maroo A, Young JB. Ischemic heart disease and congestive heart failure in diabetic patients. Med Clin North Am. 2004;88:1037-61.
4. Nesto RW. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Am J Cardiovasc Drugs. 2005;5: 379-87.
5. Betteridge, Lipid disorders in diabetes mellitus, in: JC Pickup, G Williams, editor, Text Book of Diabetes, 2nd. London: Blackwell Science; 1997, p. 55.1-55.31.
6. Marinangeli CP, Varady KA and Jones PJ. Plant sterols combined with exercise for the treatment of hypercholesterolemia: overview of independent and synergistic mechanisms of action. J Nutr Biochem. 2006;17:217-24.
7. Sajjadi SE, Movahedian A and Yektaian A. Antihyperlipidemic effect of hydroalcoholic extract and polyphenolic fraction from Dracocephalum kotschyi Boiss. Pharm Acta Helv. 1998;73:167-70.
8. Movahedian A, Sadeghi H, Ghannadi A, Gharavi M, Azarpajooh S. Hypolipidemic activity of Allium Porrum L. in cholesterol-fed rabbits. J Med Food. 2006;9:98-101.
9. Movahedian A, Ghannadi A, Vashirnia M. Hypocholesterolemic effects of Purslane extract on serum lipids in rabbits fed with high cholesterol levels. Int J Pharmacol. 2007;3:285-9.
10. Kumari CS, Govindasamy S, Sukumar E. Lipid lowering activity of Eclipta prostrata in experimental hyperlipidemia. J. Ethnopharmacol. 2006;105:332-5.
11. Pari L, Latha M. Antihyperlipidemic effect of Scoparia dulcis (sweet broomweed) in streptozotocin diabetic rats. J Med Food. 2006;9:102-7.
12. Thompson Coon JS, Ernest E. Herbs for serum cholesterol reduction: a systematic view. J Fam Pract. 2003;52:468-78.
13. Scientiae M. A taxonomic study of the Cape species of Peucednum (Apioideae, Apiaceae). [dissertation]. Johannesburg: University of Johannesburg; 2006.
14. Aida Y, Kasama T, Takeuchi N, Chiba M, Tobinaga S. Pharmacological activities of khellactones, compounds isolated from Peucedanum japonicum THUNB. and Peucedanum praeruptorium DUNN. Methods Find Exp Clin Pharmacol. 1998;20:343-51.
15. Ji Y, Rao MR. Effects of Peucedanum praeruptorum extractum on blood pressure, left ventricular hypertrophy and hemodynamic changes in left ventricular hypertrophied hypertensive rats. Chin J Integr Trad Med. 1996;16:676-8.
16. Lee SO, Choi SZ, Lee JH, Chung SH, Park SH, Kang HC, et al. Antidiabetic coumarin and cyclitol compounds from Peucedanum japonicum. Arch Pharm Res. 2004;27:1207-10.
17. Schillaci D, Venturella F, Venuti F, Plescia F. Antimicrobial and antiproliferative activity of Peucedanum nebrodense (Guss.) Strohl. J Ethnopharmacol. 2003;87:99-101.
18. Chen IS, Chang CT, Sheen WS, Teng CM, Tsai IL, Duh CY, et al. Coumarins and antiplatelet aggrigation constituents from Formason Peucedanum japonicum. Phytochemistry. 1996;41:525-30.
19. Eeva M, Rauha JP, Vuorela P, Vuorela H. Computer-assisted, high -performance liquid chromatography with mass spectrometric detection for analysis of coumarins in Peucedanum palustre and Angelica archangelica. Phytochem Anal. 2004;15:167-74.
20. Schinkovitz A, Gibbons S, Stavri M, COksedge MJ, Bucar F. Ostruthin: an antimycobacterial coumarin from the roots of Peucedanum ostruthium. Planta Med. 2003;69:369-71.
21. Movahedian A, Sajjadi SE. and Ahmadi M. Lipid lowering effect of aerial parts of Peucedanum pastinacifolium Boiss. & Hausskn. hydroalcoholic extract in hypercholesterolemic rats. Iran J Pharm Res. 2009;8:301-6.
22. Choi JS, Yokozawa T, Oura H. Improvement of hyperglycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, prunin. Planta Med. 1991;57:208-11.
23. Ahmed I, Lakhani MS, Gillett M, John A, Raza H. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract. 2001;51:155-61.
24. El-Hilaly J, Tahraoui A, Israili ZH, Lyoussi B. Hypolipidemic effects of acute and sub-chronic administration of an aqueous extract of Ajuga iva L. whole plant in normal and diabetic rats. J Ethnopharmacol. 2006;105:441-8.
25. Schartl M, Bocksch W, Koschyk DH, Voelker W, Karsch KR, Kreuzer J, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation. 2001;104:387-92.
26. Shoukry M, Jayyab AK. Plasma HDL in non-insulin-dependent diabetes and the effect of various types of treatment. Atherosclerosis. 1983;49:333-8.
27. Pepato MT, Mori DM, Baviera AM, Harami JB, Vendramini RC, Brunetti IL. Fruit of the jambolan tree (Eugenia jambolana Lam.) and experimental diabetes. J Ethnopharmacol. 2005;96:43-8.
28. Linsel-Nitschke P, Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov. 2005;4:193-205.
29. Calabresi L, Gomaraschi M, Franceschini G. Endothelial protection by High-Density Lipoproteins: From bench to bedside. Arterioscler Thromb Vasc Biol. 2003;23:1724-31.
30. Leontowicz H, Gorinstein S, Lojek A, Leontowicz M, Ciz M, Soliva-Fortuny R, et al. Comparative content of some bioactive compounds in apples, peaches and pears and their influence on lipids and antioxidant capacity in rats. J Nutr Biochem. 2002;13:603-10.
31. Kimura Y and Okuda H. Effects of active compounds isolated from Angelica shikokiana on lipid metabolism in fat cells. J Ethnopharmacol. 1989;25:269-80.
32. Ogawa H, Nakamura R and Baba K. Beneficial effect of laserpitin, a coumarin compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2005;32:1104-09.